Clinical Trial Update: Study of HRS-2189 Combined HRS-5041 in Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of HRS-2189 and HRS-5041 in metastatic prostate cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• HRS-2189
• HRS-5041

Snippet

Sponsor: Fudan University | Conditions: Prostate Cancer Metastatic Disease | Phase 2 | Status: NOT_YET_RECRUITING